Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Mallinckrodt
Dow
Harvard Business School
McKesson

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Patent Applications for ADASUVE

See Plans and Pricing

« Back to Dashboard

US Patent Applications for ADASUVE

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Start Trial   Start Trial FATTY ACID-PHARMACEUTICAL AGENT CONJUGATES 2000-12-05 Patented Case 2003-05-21
  Start Trial   Start Trial Low dose modafinil for enhancement of cognitive function 2001-02-08 Abandoned -- Failure to Respond to an Office Action 2002-08-09
  Start Trial   Start Trial POLYMORPHIC FORM OF A TACHYKININ RECEPTOR ANTAGONIST 2001-05-07 Patented Case 2002-07-25
  Start Trial   Start Trial OSMOTIC DEVICE CONTAINING VENLAFAXINE AND AN ANTI-PSYCHOTIC AGENT 2000-11-30 Patented Case 2003-05-14
  Start Trial   Start Trial HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS 2000-12-14 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2015-07-27
  Start Trial   Start Trial 2,3,4,4A-TETRAHYDRO-1H-PYRAZINO-[1,2A] QUINOXALIN-5- (6H) ONE DERIVATIVES 2001-06-26 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2010-12-06
  Start Trial   Start Trial Solubility parameter based drug delivery system and method for altering drug saturation concentration 2001-05-21 Abandoned -- Failure to Respond to an Office Action 2002-03-25
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Harvard Business School
Moodys
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.